{"id":"W2754041380","doi":"10.1056/nejmoa1612917","title":"Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2143,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Exenatide; Hazard ratio; Myocardial infarction; Placebo; Interquartile range; Internal medicine; Stroke (engine); Diabetes mellitus; Type 2 diabetes; Heart failure; Confidence interval; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01492942373253294,"score_gpt":0.2697077822158324,"score_spread":0.2547783584832994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}